Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context.

Human Molecular Genetics
Vicente SancenonPaul J Muchowski

Abstract

The aggregation of α-synuclein (αSyn) is a neuropathologic hallmark of Parkinson's disease and other synucleinopathies. In Lewy bodies, αSyn is extensively phosphorylated, predominantly at serine 129 (S129). Recent studies in yeast have shown that, at toxic levels, αSyn disrupts Rab homeostasis, causing an initial endoplasmic reticulum-to-Golgi block that precedes a generalized trafficking collapse. However, whether αSyn phosphorylation modulates trafficking defects has not been evaluated. Here, we show that constitutive expression of αSyn in yeast impairs late-exocytic, early-endocytic and/or recycling trafficking. Although members of the casein kinase I (CKI) family phosphorylate αSyn at S129, they attenuate αSyn toxicity and trafficking defects by an S129 phosphorylation-independent mechanism. Surprisingly, phosphorylation of S129 modulates αSyn toxicity and trafficking defects in a manner strictly determined by genetic background. Abnormal endosome morphology, increased levels of the endosome marker Rab5 and co-localization of mammalian CKI with αSyn aggregates are observed in brain sections from αSyn-overexpressing mice and human synucleinopathies. Our results contribute to evidence that suggests αSyn-induced defects in en...Continue Reading

References

Mar 30, 1976·Acta Neuropathologica·L S Forno, R L Norville
Jan 1, 1992·Current Genetics·D C ChenT T Kuo
Aug 19, 1991·Neuroscience Letters·L A HansenD Rexin
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·K RoseJ Engebrecht
Mar 7, 1997·The Journal of Biological Chemistry·D E KrantzR H Edwards
May 23, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·L A HansenS Love
Jan 5, 2000·The Journal of Biological Chemistry·M OkochiC Haass
Jan 19, 2000·Molecular Biology of the Cell·M J LewisH R Pelham
May 18, 2000·Brain Research·K YasojimaP L McGeer
Jun 15, 2000·The Journal of Biological Chemistry·A N ProninJ L Benovic
Nov 10, 2000·Molecular Biology of the Cell·F ReggioriH R Pelham
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·E MasliahL Mucke
Nov 8, 2001·Journal of Molecular Biology·J B Pereira-Leal, M C Seabra
Jan 29, 2002·Nature Cell Biology·Hideo FujiwaraTakeshi Iwatsubo
Jul 26, 2002·Nature·Guri GiaeverMark Johnston
Aug 16, 2002·Molecular Biology of the Cell·Sidney Yu, Michael G Roth
May 14, 2003·The Journal of Biological Chemistry·Elizabeth A VealBrian A Morgan
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
Dec 6, 2003·Science·Tiago Fleming Outeiro, Susan Lindquist
Aug 12, 2004·FEBS Letters·Yu HiraiMasato Hasegawa
Oct 29, 2004·The EMBO Journal·Shumin LiuOttavio Arancio
Feb 25, 2005·Investigative Ophthalmology & Visual Science·Jorge M C MalbouissonGilmasa D Rios
Apr 28, 2005·Neuroscience Letters·E Dalfó, I Ferrer

❮ Previous
Next ❯

Citations

Aug 29, 2013·Proceedings of the National Academy of Sciences of the United States of America·Abid OueslatiHilal A Lashuel
Aug 13, 2013·Oxidative Medicine and Cellular Longevity·V FranssensJ Winderickx
Apr 29, 2015·Biomolecules·Blagovesta PopovaGerhard H Braus
Nov 21, 2015·Human Molecular Genetics·Sandra TenreiroTiago Fleming Outeiro
May 27, 2014·Frontiers in Molecular Neuroscience·Sandra TenreiroTiago F Outeiro
Feb 25, 2017·Current Opinion in Genetics & Development·Sandra TenreiroTiago Fleming Outeiro
Jul 2, 2014·Neurobiology of Disease·Guowei YinMarkus Zweckstetter
Jan 16, 2018·Parkinson's Disease·Juan Antonio Castillo-GonzalezHumberto Rodriguez-Rocha
Aug 19, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel F TardiffSusan Lindquist
Sep 27, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Vibha PrasadAaron Voigt
Mar 8, 2017·Pharmacological Reviews·Ying C Li, Ege T Kavalali
Oct 3, 2018·FEMS Yeast Research·Inês Caldeira BrásTiago F Outeiro
May 14, 2020·The FEBS Journal·Patrícia I Santos, Tiago F Outeiro
Feb 11, 2020·Frontiers in Neuroscience·Luis D Bernal-CondeMagdalena Guerra-Crespo
Sep 19, 2014·The Journal of Biological Chemistry·Hedieh ShahpasandzadehGerhard H Braus
Apr 21, 2021·Brain : a Journal of Neurology·Francesca PischeddaGiovanni Piccoli
May 4, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·David J KossTiago F Outeiro
Jan 28, 2015·The Journal of Physical Chemistry. B·József KardosAndrás Perczel
Nov 5, 2014·ACS Chemical Neuroscience·Sujit BasakKrishnananda Chattopadhyay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Aaron D GitlerSusan Lindquist
The Journal of Biological Chemistry
Martial K MbefoHilal A Lashuel
© 2022 Meta ULC. All rights reserved